<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871126</url>
  </required_header>
  <id_info>
    <org_study_id>CHA2DS2-VASc score</org_study_id>
    <nct_id>NCT04871126</nct_id>
  </id_info>
  <brief_title>Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction</brief_title>
  <official_title>Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for Left Ventricular Thrombus in Acute Anterior Myocardial Infarction With Left Ventricular Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henan Provincial People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the predictive value of inflammatory indexes and CHA2DS2-VASc score for&#xD;
      anterior myocardial infarction (ANT-MI) with left ventricular thrombus(LVT) (LVT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical data were collected from 371consecutive patients with ANT-MI in our hospital&#xD;
      from January 2014 to January 2021.As a result,totally 62 patients with LVT were selected as&#xD;
      the experimental group and 186 patients with non-LVT as the control group .The observation&#xD;
      indexes included baseline data, coronary angiography, disease course, laboratory examination&#xD;
      and auxiliary examination.Patients with severe organic disease and having previous history of&#xD;
      left ventricular aneurysm( LVA) and LVT were excluded.Data was analyzed by software SPSS 22.0&#xD;
      for statistical analysis,and the logistic regression model was established.A P&lt;0.05 was&#xD;
      considered statistically significant, and the risk factors of LVT formation were&#xD;
      retrospectively analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the predictive of the inflammatory indexes and CHA2DS2-VASc score in LVT</measure>
    <time_frame>Day 1</time_frame>
    <description>the logistic regression model was established between the indexes and LVT</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">371</enrollment>
  <condition>Left Ventricular Thrombus</condition>
  <condition>Acute Anterior Myocardial Infarction</condition>
  <condition>Left Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>LVT group</arm_group_label>
    <description>left ventricular thrombus in acute anterior myocardial infarction patients with left ventricular dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-LVTgroup</arm_group_label>
    <description>acute anterior myocardial infarction patients with left ventricular dysfunction while without LVT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>inflammatory indexes and CHA2DS2-VASc score</intervention_name>
    <description>inflammatory indexes and CHA2DS2-VASc score</description>
    <arm_group_label>LVT group</arm_group_label>
    <arm_group_label>non-LVTgroup</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study included a total of 371 patients with anterior myocardial infarction (ANT-MI)&#xD;
        treated with emergency prior percutaneous coronary intervention (pPCI) in our hospital&#xD;
        betweenfrom January 2014 andto January 2021. Patients were eligible for enrollmentenrolment&#xD;
        if they had a reduced left ventricularLV ejection fraction (LVEF) ( â‰¤40%). and if detailed&#xD;
        data on demographic and clinical characteristics were documented. Exclusion criteria were&#xD;
        end-stage organic disease, thrombotic hematological disorders, previous anticoagulant use,&#xD;
        and poor echogenicity (Figure 1). Based on the study criteria, 123 patients were excluded&#xD;
        from the study; thus, 248 patients were included in the analysis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        acute anterior myocardial infarction with left ventricular dysfunction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        end-stage organic disease, thrombotic hematological disorders, previous anticoagulant use,&#xD;
        and poor echogenicity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>left ventricular thrombus;anterior myocardial infarction</keyword>
  <keyword>Risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
    <mesh_term>Anterior Wall Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

